Navigation Links
Doctors to give complete information on prescriptions to patients

A recent research by scientists at the University of California in Los Angeles reveals that in general, doctors give only 62% of the information to patients for them to take the medication properly. //

“This is a good indication that there is actually a lack of communication between patients and doctors,” said the lead author Derjung M. Tarn. The study is published in the Sept. 25 volume of the journal Archives of Internal Medicine.

In order to find out if the five main points of information are being communicated to the patients, the researchers carried out at investigation on 185 outpatient visits to 44 physicians. The 5 key points are the name of the medication, the purpose for taking it, the duration of use, possible adverse effects and the number and frequency of doses.

The study revealed that at least one of the key points was missed by most of the patients. Doctors gave the name of the medication in 74% of new prescriptions; the purpose of it was elaborated in 87% of cases and the undesirable effects of it were discussed in 35% of the cases. The duration of medication was discussed in only 1/3rd of the cases, the number of tablets to be taken was told in 55% of the cases and the frequency or timing of the dos in 58%.

“Healthcare providers seemed to make more of an effort to convey information about analgesic and psychiatric medication, but compared to how doctors should do, that is not enough,” said Tarn. “Doctors should be able to hit all five points. If patients do not hear the information at the physician`s office, they may not get it elsewhere,” she added.

“A lot of this information is not on the package insert. And when that information is missing, patients may not take their medication appropriately, leading to medical errors and unnecessary hospitalizations,” she said.

According to a study released by the Institutes of Medicine in July over 1.5 million people are affected by
'"/>




Page: 1 2 3

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Emphasis to ban Drugs ads by Doctors
7. Doctors not to accept gifts from drug companies
8. Gene testing kit specific for Doctors
9. Doctors warned of fluoride toxicity
10. Doctors decisions are affected by fear of lawsuits- says a study
11. Bihar High Court Intervenes To End Doctors Strike
Post Your Comments:
(Date:12/5/2009)... new three-drug combination has shown in a phase 1/2 ... regimen" in the treatment of patients newly diagnosed with ... bone marrow, say researchers from Dana-Farber Cancer Institute. , ... the 66 patients treated with the drug combination in ... good partial response rate" in the phase 2 population, ...
(Date:12/5/2009)... of Blood Cancer Is Most Challenging-- ,, ... have identified specific genes, dubbed partner genes, that fuse ... leukemia in infants. By more accurately defining specific partner ... benefit from particular treatments. ,, Oncologists also aim ...
(Date:12/5/2009)... companies develop and test their cleaning processes. The technology available to ... and solve problems for customers relating to cleaning parts, process development, ... ... Midbrook, Inc , a Jackson, MI-based company, is home to ...
(Date:12/4/2009)... Medical Systems (NYSE: VAR ) announced today that ... Meeting of Stockholders for February 11, 2010 with a record ... at the Crowne Plaza Cabana Hotel, 4290 El Camino Real, ... will be webcast by Thomson Financial and can be accessed ...
(Date:12/4/2009)... Allied World Assurance,Company Holdings, Ltd (NYSE: ... Executive Officer, and Jack Sennott, Executive Vice,President and Chief ... Sachs U.S. Financial Services Conference being held at the ... December 8, 2009. ,, About ...
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
... MD, offers tips to minimize riskACL tears in girls ... "Exercise and sports participation is a double-edge sword," ... Packard Children,s Hospital at Stanford . "We want ... have an obesity crisis. Yet you can have too ...
... March 3 Thoratec Corporation,(Nasdaq: THOR ), ... save, support and restore failing hearts, said today that ... Institutional Investors,Conference on Monday, March 9. , ... financial officer, will,provide an update on the company, beginning ...
... Evidence-Based Care Guidelines will be used to Combat Waste ... a permanent Recovery Audit Contractor (RAC) for the Centers ... five-year license agreement with Milliman Care Guidelines (R). ... content and software to review Medicare claims. HDI is ...
... /PRNewswire-Asia/ -- , Tigermed ... in China, and Qiming Venture, a premier venture ... asset injection to MacroStat, the unique CRO in,China ... The,union between the two top CROs will significantly ...
... N.C., March 3 MedCath Corporation (Nasdaq: ... a presentation at the Raymond James & Associates 30th ... JW Marriott Grande Lakes in Orlando, Florida. MedCath,s senior ... at 1:40 pm Eastern time. The presentation will ...
... Inc. today announced the addition of Andrew T. ... addition increases board membership to 4.(Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO ... of the Medical Solutions Fund of Siemens Venture ... Prior to joining Siemens Venture Capital, he ...
Other Medicine News:Health News:Kids' 'Overuse' Sports Injuries Are on the Rise 2Health News:Recovery Audit Contractor HealthDataInsights Licenses Milliman Care Guidelines(R) 2Health News:Recovery Audit Contractor HealthDataInsights Licenses Milliman Care Guidelines(R) 3Health News:Tigermed and Qiming Venture Grant Asset Injection to MacroStat 2Health News:CorNova Announces Addition of Andrew T. Jay, D.M.D., M.B.A., to its Board of Directors 2
(Date:12/4/2009)... Dec. 4 Drs. Neal Shore and E. David ... the additional analysis of secondary end points of biochemical ... FIRMAGON® (monthly degarelix for injection) or monthly leuprolide in ... Prostate cancer patients who received FIRMAGON 240/80 mg/month ...
(Date:12/4/2009)... AstraZeneca (NYSE: AZN ) today announced that ... once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as ... Depressive Disorder (MDD). SEROQUEL XR is the only medication ... both major depressive disorder as adjunctive therapy and acute ...
(Date:12/3/2009)... NEW YORK, Dec. 3 Guidepoint Global, LLC , ... their Sleep Apnea Tracker, a monthly longitudinal data release that ... Sleep Apnea market. ,, The Sleep Apnea Tracker captures ... sold in the United States from 15 different equipment providers ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Apollo Health Street Collaborates with Client to Develop a CCHIT Certified 08 Ambulatory EMR 48571 1Apollo Health Street Collaborates with Client to Develop a CCHIT Certified 08 Ambulatory EMR 48571 2Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 1Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 2Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 3Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 4Industry Partners Step Up To Help Blood Cancer Patients 48567 1Industry Partners Step Up To Help Blood Cancer Patients 48567 2
... vitro microbiology and proof of concept in topical ... March 2007 - Arpida Ltd.,(SWX: ARPN) today announced ... against a large panel of,clinical isolates, including those ... of AR-2474 were found,to be highly effective in ...
... Texas, March 8, 2007--The World Health Organization,has ... cases are rising in,Pakistan. , So is ... constantly,claim, the pharmaceutical industry is denying important ... According to London’s Guardian,newspaper, “parents of ...
Other Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Why Is Polio Spreading in Pakistan? 2
EC+ Extra Care Bariatric Bed...
... Excel Care ES bed is especially designed ... empowered, while protecting the caregivers who manage them. ... the most routine tasks pulling up in ... to caregivers and disheartening for patients. Excel Care ...
... Disposable Prefilled 28%-100% FIO 2 500ML 0.45% ... nebulizers provide unmatched performance and ease of use. ... adjustable from 28% to 100% FIO 2 . ... water for inhalation, USP; 0.45% sodium chloride inhalation, ...
... Nebulizer Disposable Prefilled 28%-100% FIO 2 ... ,Our prefilled nebulizers provide unmatched performance and ... cool high-output aerosols adjustable from 28% to 100% ... of solutions: sterile water for inhalation, USP; 0.45% ...
Medicine Products: